Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount

Thread starter International: Top News And Analysis
Start date Nov 5, 2025

International: Top News And Analysis

Guest

Nov 5, 2025

Novo Nordisk is currently locked in a bidding war with Pfizer for U.S. biotech firm Metsera.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount

Prefix: N/A

Forum: World News

Start date: Nov 5, 2025

Last reply date: Nov 5, 2025

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Nov 5, 2025

Replies: 0

Views: 17

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search